相关实验视频
Updated: Jul 1, 2026

09:55
Monitoring Acupuncture Effects on Human Brain by fMRI
Published on: April 8, 2010
15.4K
针在急诊室 (ACUITY):来自BraveNet多中心可行性随机对照试验的结果
Jeffery A Dusek1,2, Gene A Kallenberg3, Alan B Storrow4
1Department of Medicine, University of California- Irvine, Irvine, CA, USA.
Integrative medicine research
|December 6, 2024
概括
这项研究表明,针是一种可行的,可接受的非药物治疗疼痛管理在急诊室的选择. 它达到了招聘目标,并显示了减少疼痛和焦虑的潜力.
科学领域:
- 紧急医疗 紧急医疗
- 综合医学是一个整体的医学.
- 临床试验 临床试验
背景情况:
- 疼痛是急诊室 (ED) 访问的常见原因,需要安全,有效的非药物疼痛管理策略.
- 之前对ED针的研究表明,针可以减少疼痛,副作用很少,但往往是小规模的,单一的.
研究的目的:
- 评估在ED中进行针治疗急性疼痛的多中心随机对照试验 (RCT) 的可行性.
- 评估针作为ED疼痛干预的招募,保留和参与者/提供者的接受度.
主要方法:
- ACUITY研究是一项前性设计的多中心可行性RCT,涉及3个ED的165名患有急性非突发性疼痛 (≥4/10) 的成年人.
- 参与者被随机分配到针或常规护理,在基线和治疗后45-60分钟评估疼痛和焦虑.
- 主要可行性结果是招聘率;次要结果包括保留和接受度.
主要成果:
- 该研究成功招募了632名参与者中的165名参与者 (26.1%的招聘率),达到可行性目标.
- 针被发现对参与者和医疗保健提供者来说都是可以接受的.
- 针治疗的平均疼痛分数从7.4降至4.8,而通常护理的7.1降至6.4;针治疗的焦虑分数也下降了更多.
结论:
- ACUITY试验成功地证明了一个更大的,最终的多中心RCT研究针治疗ED疼痛的可行性.
- 初步数据表明,针可能是急诊室疼痛和焦虑管理的可行选择.
更多相关视频
04:06Author Spotlight: Using a 3D-Printed Holder for Simultaneous Multiple Electroacupuncture Operation
Published on: September 1, 2023
604
07:29Author Spotlight: Development of a Standardized Acupuncture Tool Inspired by Advanced Techniques for Improved Safety and Precision
Published on: January 10, 2025
259
相关概念视频
Acute Coronary Syndrome III: Diagnostic Studies
Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
Hazard Ratio
The hazard ratio (HR) is a widely used measure in clinical trials to compare the risk of events, such as death or disease recurrence, between two groups over time. It reflects the ratio of hazard rates—the instantaneous risk of the event occurring—between a treatment group and a control group. This measure provides valuable insights into the relative effectiveness of a treatment by assessing how the risk of an event differs between the two groups.
For example, in a clinical trial evaluating a...
For example, in a clinical trial evaluating a...